Login Register Cart 0
Generic placeholder image

Recent Patents on Drug Delivery & Formulation

Editor-in-Chief

ISSN (Print): 1872-2113
ISSN (Online): 2212-4039

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Development of the Modified Ocimum gratissimum Seeds for Orally Disintegrating Tablets

Author(s): Yen N.T. Dang, Phuong H.L. Tran and Thao T.D. Tran*

Volume 14, Issue 1, 2020

Page: [40 - 47] Pages: 8

DOI: 10.2174/1872211313666191029144038

Abstract

Background: Natural materials have been encouraged in controlled drug release and improved drug bioavailability.

Objective: This study aimed to develop a modification process for the use of a natural material, Ocimum gratissimum seeds (OGS), in Orally Disintegrating Tablets (ODTs).

Methods: The OGS was investigated with four different modification processes including only milling, swelling, swelling/milling, and swelling/milling/incubation. The ODTs containing the modified OGS as a disintegrant were prepared by the wet granulation method. Furthermore, an evaluation to assess parameters of tablets, such as weight variation, hardness, friability, wetting time, disintegration time, drug content, and dissolution studies, was performed.

Results: The modification of OGS using the swelling/ milling process resulted in a completion of OGS modification, leading to an ideal wetting time, disintegrating time, and dissolution rate. The OGS concentrations also affected the wetting and disintegrating time with the optimal range of ODTs from 15% to 20%. On the other hand, the modification with the incubation processes varied by temperature and time increased the wetting time and disintegrating time.

Conclusions: The modified OGS demonstrated that it is a potential material with the advantages of cost-effectiveness, non-toxicity and easy manufacture in the preparation of ODTs.

Keywords: Orally disintegrating tablets, Ocimum gratissimum seeds, disintegrant, modification, oral delivery, natural material.

« Previous Next »
Graphical Abstract

[1]
Luu T, Phan N, Tran T-D, Van Vo T, Tran P-L. Use of Microwave Method for Controlling Drug Release of Modified Sprouted Rice Starch. Toi VV, Lien Phuong TH, (Eds.). In: 5th International Conference on Biomedical Engineering in Vietnam. pp. 314-6, 2015.
[http://dx.doi.org/10.1007/978-3-319-11776-8_76]
[2]
Herman J, Remon J, De Vilder J. Modified starches as hydrophilic matrices for controlled oral delivery. I. Production and characterisation of thermally modified starches. Int J Pharm 1989; 56: 51-63.
[http://dx.doi.org/10.1016/0378-5173(89)90060-4]
[3]
Herman J, Remon J. Modified starches as hydrophilic matrices for controlled oral delivery. II. In vitro drug release evaluation of thermally modified starches. Int J Pharm 1989; 56: 65-70.
[http://dx.doi.org/10.1016/0378-5173(89)90061-6]
[4]
Herman J, Remon J. Modified starches as hydrophilic matrices for controlled oral delivery III. Evaluation of sustained-release theophylline formulations based on thermal modified starch matrices in dogs. Int J Pharm 1990; 63: 201-5.
[http://dx.doi.org/10.1016/0378-5173(90)90125-N]
[5]
Talukdar MM, Michoel A, Rombaut P, Kinget R. Comparative study on xanthan gum and hydroxypropylmethyl cellulose as matrices for controlled-release drug delivery I. Compaction and in vitro drug release behaviour. Int J Pharm 1996; 129: 233-41.
[http://dx.doi.org/10.1016/0378-5173(95)04355-1]
[6]
Peerapattana J, Phuvarit P, Srijesdaruk V, Preechagoon D, Tattawasart A. Pregelatinized glutinous rice starch as a sustained release agent for tablet preparations. Carbohydr Polym 2010; 80: 453-9.
[http://dx.doi.org/10.1016/j.carbpol.2009.12.006]
[7]
Balmayor ER, Tuzlakoglu K, Marques AP, Azevedo HS, Reis RL. A novel enzymatically-mediated drug delivery carrier for bone tissue engineering applications: Combining biodegradable starch-based microparticles and differentiation agents. J Mater Sci Mater Med 2008; 19(4): 1617-23.
[http://dx.doi.org/10.1007/s10856-008-3378-5] [PMID: 18214645]
[8]
Reis AV, Guilherme MR, Moia TA, Mattoso LH, Muniz EC, Tambourgi EB. Synthesis and characterization of a starch‐modified hydrogel as potential carrier for drug delivery system. J Polym Sci A Polym Chem 2008; 46: 2567-74.
[http://dx.doi.org/10.1002/pola.22588]
[9]
Nair A, Bhatnagar PS, Ghosh B, Parcha V. Studies on Ocimum gratissimum seed mucilage: Evaluation of suspending propertie. 2005.
[10]
Ravikumar, Shirwaikar AA, Shirwaikar A, Prabu DL, Mahalaxmi R, Rajendran K, Kumar CD. Studies of disintegrant properties of seed mucilage of Ocimum gratissimum. Indian J Pharm Sci 2007; 69(6): 753-8.
[11]
Gupte A, Karjikar M, Nair J. Biosorption of copper using mucilaginous seeds of Ocimum basilicum. Acta Biologica Indica 2012; 1(1): 113-9.
[12]
Zhou D, Jacob B, Welbaum GE. The Production and Function of Mucilage by Sweet Basil (Ocimum basilicum L.) Seeds Virginia Polytechnic Institute and State University, Blacksburg VA, USA..
[13]
Parkash V, Maan S. Deepika, Yadav SK, Hemlata, Jogpal V. Fast disintegrating tablets: Opportunity in drug delivery system. J Adv Pharm Technol Res 2011; 2(4): 223-35.
[http://dx.doi.org/10.4103/2231-4040.90877] [PMID: 22247889]
[14]
Kiniwa R, Miyake M, Kimura SI, Itai S, Kondo H, Iwao Y. Development of muco-adhesive orally disintegrating tablets containing tamarind gum-coated tea powders for oral care. Int J PharmX 2019. 1100012
[http://dx.doi.org/10.1016/j.ijpx.2019.100012] [PMID: 31517277]
[15]
Wagner-Hattler L, Wyss K, Schoelkopf J, Huwyler J, Puchkov M. In vitro characterization and mouthfeel study of functionalized calcium carbonate in orally disintegrating tablets. Int J Pharm 2017; 534(1-2): 50-9.
[http://dx.doi.org/10.1016/j.ijpharm.2017.10.009] [PMID: 28987455]
[16]
Olah I, Lasher J, Regdon G, Pintye-Hodi K, Baki G, Sovany T. Evaluating superdisintegrants for their performance in orally disintegrating tablets containing lysozyme enzyme. J Drug Deliv Sci Technol 2019; 49: 396-404.
[http://dx.doi.org/10.1016/j.jddst.2018.12.012]
[17]
Nishiyama T, Ogata T, Ozeki T. Preparation of bitter taste-masking granules of lafutidine for orally disintegrating tablets using water-insoluble/soluble polymer combinations. J Drug Deliv Sci Technol 2016; 32: 38-42.
[http://dx.doi.org/10.1016/j.jddst.2016.01.005]
[18]
Badgujar BP, Mundada AS. The technologies used for developing orally disintegrating tablets: A review. Acta Pharm 2011; 61(2): 117-39.
[http://dx.doi.org/10.2478/v10007-011-0020-8] [PMID: 21684842]
[19]
Sammour OA, Hammad MA, Megrab NA, Zidan AS. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS PharmSciTech 2006; 2: 55.
[20]
Fu Y, Yang S, Jeong SH, Kimura S, Park K. Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies. Critical Reviews™ in Therapeutic Drug Carrier Systems 2004; 21(6): 433-475.
[21]
European Pharmacopoeia. (EP 8.0) Strasbourg. Strasbourg 2014.Development of the Modified Ocimum gratissimum Seeds Recent Patents on Drug Delivery & Formulation, 2020, Vol. 14, No. 1 47.
[22]
Türkmen Ö, Ay Şenyiğit Z, Baloğlu E. Formulation and evaluation of fexofenadine hydrochloride orally disintegrating tablets for pediatric use. J Drug Deliv Sci Technol 2018; 43: 201-10.
[http://dx.doi.org/10.1016/j.jddst.2017.10.008]
[23]
Pawar H, Varkhade C, Jadhav P, Mehra K. Development and evaluation of orodispersible tablets using a natural polysaccharide isolated from Cassia tora seeds. Integr Med Res 2014; 3(2): 91-8.
[http://dx.doi.org/10.1016/j.imr.2014.03.002]

Rights & Permissions Print Cite
Article Metrics
4
© 2024 Bentham Science Publishers | Privacy Policy